In this course, a general overview of existing and novel biomarkers in Alzheimer's disease will be reviewed, including imaging and blood based. The course will discuss current evidence for the utility of these biomarkers in understanding cognitive aging and Alzheimer's disease. The interplay between neuropsychology and these biomarkers will be discussed and how neuropsychology provides "added value" to patients and participants in clinical research and clinical trials. Finally, a review of how these biomarkers present, as well as the clinical impact, among diverse populations will be provided.
Learning Objectives:
Discuss the current landscape of biomarkers in Alzheimer's disease
Describe how these biomarkers have been integrated into research and clinical settings
Explain how neuropsychology provides added value to these biomarkers for both clinical and research use
Explain how race/ethnicity impacts these biomarkers as well as the link between these biomarkers and clinical outcomes
